The word “peptide” on a product label or protocol menu tells you almost nothing useful. Peptides are a structural category — short chains of amino acids — not a functional one. A peptide that signals fibroblasts to produce collagen operates by a completely different mechanism than one that modulates the skin’s barrier proteins, or one that affects melanin distribution, or one that targets mitochondrial function in aging skin cells.
The preclinical literature on skin-relevant peptides is extensive. But it only becomes actionable if you understand which type of peptide you’re looking at and what mechanism it’s working through. Here’s how researchers and practitioners are currently categorizing the landscape.
Free Peptide Research Guide 2026/2027
Download our comprehensive research guide — evidence-based peptide science insights for healthcare practitioners and researchers.
1. Collagen-Signaling Peptides
The most studied category in aesthetic research. These peptides act on the fibroblast — the cell type responsible for synthesizing the structural proteins that give skin its thickness and elasticity. Rather than being structural components themselves, they function as signaling molecules that influence gene expression in fibroblast populations.
The most extensively researched compound in this category is GHK-Cu (copper tripeptide-1). Preclinical models have investigated GHK-Cu’s effects on collagen synthesis, elastin production, matrix metalloproteinase (MMP) regulation, and angiogenesis. The research on MMP modulation is particularly interesting: MMPs are the enzymes that break down existing collagen matrix, and GHK-Cu appears in multiple studies to influence the MMP/TIMP balance in ways that favor matrix preservation. Animal and in vitro models have also shown effects on fibroblast proliferation and migration — mechanisms directly relevant to wound healing and post-procedure recovery contexts.
The preclinical literature on GHK-Cu spans decades and is among the most robust bodies of evidence for any aesthetic peptide compound. It’s available through Hello Stacks at research grade for research use only.
What this means for protocol research
Collagen-signaling peptides are most relevant in post-procedure windows where fibroblast activity is elevated — the inflammatory and proliferative phases following micro-needling, laser, or RF treatments. The preclinical rationale for timing GHK-Cu protocols to coincide with these windows is well-supported in the research literature, even as clinical confirmation in human subjects continues to develop.
2. Barrier-Repair and Anti-Inflammatory Peptides
A distinct category targeting the skin’s structural barrier function and immune response. The stratum corneum’s integrity depends on a complex of structural proteins, lipids, and intercellular junctions. When this barrier is compromised — by procedure trauma, environmental stress, or underlying inflammation — the downstream effects include transepidermal water loss, sensitivity, and impaired healing.
KPV (Lys-Pro-Val) is the primary research compound in this category within the Hello Stacks and Stack One catalog. KPV is a C-terminal fragment of alpha-MSH (alpha-melanocyte stimulating hormone) and has been studied extensively in preclinical inflammation models. Research has investigated its effects on NF-κB signaling pathways, cytokine modulation, and intestinal inflammation — with growing interest in topical and transdermal applications for skin barrier contexts.
The anti-inflammatory mechanism is distinct from barrier-structural repair, but the two are functionally linked: reducing pro-inflammatory signaling supports the conditions in which barrier integrity can be restored. For post-procedure research protocols where inflammation management is a key variable, KPV represents an interesting compound with a meaningful preclinical foundation.
What this means for protocol research
Barrier-repair category peptides are most relevant in recovery-phase protocols and in client populations where baseline skin sensitivity or compromised barrier function is a factor — rosacea-prone skin, post-ablative procedures, and inflammatory skin conditions are the contexts where researchers are paying closest attention.
3. Tissue Repair and Regeneration Peptides
A broader category that extends beyond the skin-specific mechanisms above into systemic tissue repair biology. The distinction matters because some of the most interesting research on these compounds comes from musculoskeletal and gastrointestinal contexts — and the underlying cellular mechanisms appear to translate across tissue types.
BPC-157 (Body Protection Compound-157) is the most-studied compound in this category in the Hello Stacks/Stack One catalog. Derived from a protein found in gastric juice, BPC-157 has been investigated across a wide range of tissue repair contexts in animal models: tendon repair, wound healing, vascular integrity, and nerve regeneration among them. The proposed mechanisms include effects on nitric oxide signaling, VEGF (vascular endothelial growth factor) activity, and growth hormone receptor interaction — all pathways with relevance to healing and tissue remodeling.
TB-500 (Thymosin Beta-4 fragment) is often studied alongside BPC-157 and addresses a different mechanism: actin regulation and cellular migration. Actin is the cytoskeletal protein that enables cells to move — a prerequisite for tissue repair, where fibroblasts, endothelial cells, and immune cells must migrate to sites of damage. Preclinical research on TB-500 has investigated its role in wound healing, cardiac repair, and neurological injury models.
Hello Stacks offers a pre-formulated GHK-Cu + BPC-157 + TB-500 research stack (70mg) for researchers studying multi-mechanism approaches to tissue repair and skin recovery.
What this means for protocol research
Tissue repair peptides are the category most relevant to aesthetic recovery protocols — the period between procedure and visible result where the quality of healing determines the outcome. The BPC-157/TB-500 research literature suggests these compounds may support the biology of that recovery window, even as human clinical data continues to develop.
4. Melanin-Modulating Peptides
A specialized category targeting the melanocyte — the skin cell responsible for producing melanin and determining pigmentation. Research compounds in this category interact with the MC1R receptor (melanocortin 1 receptor) and downstream cAMP signaling pathways that regulate melanin synthesis.
Melanotan 2 (MT-2) is the research compound in this category available through Hello Stacks and Stack One. MT-2 is a synthetic analog of alpha-MSH and has been studied for its effects on melanin production, UV response, and skin pigmentation in preclinical and early human research. The MC1R pathway MT-2 interacts with also has documented relevance to libido and appetite modulation — making it a compound with a complex multi-pathway research profile.
The pigmentation research on MT-2 is of particular interest in aesthetic contexts where photoprotection and controlled pigmentation outcomes are research variables — though the compound’s systemic reach means it requires careful consideration in any research protocol design.
What this means for protocol research
Melanin-modulating peptides represent the most specialized category here — relevant specifically to pigmentation research contexts and clients exploring UV response and melanin distribution questions. The research literature is substantive but the systemic mechanism profile requires more thorough informed consent and protocol documentation than topically-acting compounds.
Why the Categories Matter More Than the Compounds
Understanding which category a peptide belongs to determines what research questions it’s relevant to, what the biological rationale for timing and context looks like, and how it might complement other compounds in a stack. A collagen-signaling peptide and a tissue repair peptide may both be described as “peptides for skin” — but they’re working through completely different mechanisms and are relevant to different phases of the skin biology timeline.
The practices building substantive peptide research protocols are doing so by understanding these distinctions and designing protocols around the mechanisms — not just adding compounds to a menu because they’ve been marketed as beneficial for skin.
Questions about researching any of these compounds or designing a protocol tier for your practice? Reach out to Ted at 725.275.7267 | hellostacks.com | stackone.com
All compounds referenced are for research use only. Not FDA-approved for any clinical application. Nothing here constitutes medical or clinical advice. Consult qualified professionals before implementing any protocol in a clinical setting.